Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist
Authors:
- 1 April 2017
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 116, 371-386
Abstract
No abstract availableKeywords
Funding Information
- NINDS (5 P30 NS069375 05)
This publication has 77 references indexed in Scilit:
- The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's diseaseNeurobiology of Aging, 2012
- Thy1‐hAPPLond/Swe+ mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social functionBrain and Behavior, 2012
- Mechanisms underlying basal and learning-related intrinsic excitability in a mouse model of Alzheimer's diseaseNeurobiology of Aging, 2011
- Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down Syndrome: Activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancerNeurobiology of Disease, 2011
- Norepinephrine and ß1-adrenergic signaling facilitate activation of hippocampal CA1 pyramidal neurons during contextual memory retrievalNeuroscience, 2011
- Teaching old receptors new tricks: biasing seven-transmembrane receptorsNature Reviews Drug Discovery, 2010
- Failures to reconsolidate memory in a mouse model of Alzheimer’s diseaseNeurobiology of Learning and Memory, 2009
- Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse modelNeurobiology of Disease, 2009
- Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative DiseaseBiological Psychiatry, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008